Debulking hysterectomy followed by chemoradiotherapy versus chemoradiotherapy for FIGO stage (2019) IB3/II cervical cancer
Author:
Affiliation:
1. Manipal Hospitals, Salt Lake; Kolkata India
2. East Kent Gynaecological Oncology Centre; Queen Elizabeth The Queen Mother Hospital; Kent UK
3. Obstetrics and Gynaecology; Queen Alexandra Hospital; Portsmouth UK
Publisher
Wiley
Subject
Pharmacology (medical)
Reference58 articles.
1. Chemoradiation with and without adjuvant extrafascial hysterectomy for IB2 cervical carcinoma;Darus;International Journal of Gynecological Cancer,2008
2. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group;Keys;Gynecologic Oncology,2003
3. Chemoradiation with paclitaxel and carboplatin in high-risk cervical cancer patients after radical hysterectomy: a Korean Gynecologic Oncology Group study;Lee;International Journal of Radiation Oncology, Biology, Physics,2013
4. Comparison of the clinical efficacy of different treatments based on radical surgery in stage Ib2 and IIa2 cervical cancer: a prospective randomized control study;Li;Chinese Journal of Obstetrics and Gynecology,2016
5. Comparison of survival outcomes between radio-chemotherapy and radical hysterectomy with postoperative standard therapy in patients with stage IB1 to IIA2 cervical cancer: long-term oncological outcome analysis in 37 Chinese hospitals;Liu;BMJ (Clinical Research Ed.),2020
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Survival benefit of surgery with postoperative radiotherapy in locally advanced cervical adenocarcinoma: a population-based analysis;BMC Surgery;2023-10-03
2. TRIM21 promotes tumor progression and cancer stemness in cervical squamous cell carcinoma;Pathology - Research and Practice;2023-08
3. The diagnostic value of lncRNA HOTAIR for cervical carcinoma in vaginal discharge and serum;Medicine;2023-06-30
4. Perspectives of ERCC1 in early-stage and advanced cervical cancer: From experiments to clinical applications;Frontiers in Immunology;2023-01-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3